SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Rock Creek Pharmaceuticals, Inc. – ‘RW’ on 9/24/01

On:  Monday, 9/24/01   ·   Accession #:  1021408-1-507214   ·   File #:  333-63578

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 9/24/01  Rock Creek Pharmaceuticals, Inc.  RW                     1:3K                                     Donnelley R… Fin’l/NY/FA

Registration Withdrawal Request
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: RW          Registration Withdrawal                                2±     7K 

RWTOCTopPreviousNextBottomJust 1st
 

[LOGO] Star Scientific, Inc.-------------------------------------------------------- September 21, 2001 VIA EDGAR --------- Securities and Exchange Commission 450 Fifth Street, N.W. Washington, D.C. 20549 Re: Star Scientific, Inc. Registration Statement on Form S-3 Ladies and Gentlemen: Star Scientific, Inc. a Delaware corporation (the "Company"), pursuant to Rule 477 promulgated under the Securities Act of 1933, as amended, hereby requests that the Securities and Exchange Commission consent to the withdrawal of the Company's Registration Statement on Form S-3 (Registration No. 333-63578), together with all exhibits hereto (the "Registration Statement"). The Company requests withdrawal of the Registration Statement as the selling stockholders listed therein have informed the Company that they have now concluded all sales of shares to be conducted under the Registration Statement. The selling stockholders have sold 192,000 shares of the common stock of the Company under the Registration Statement. The Company further requests that, pursuant to Rule 477(c), an order with the date of granting of the withdrawal be included in the file for the Registration Statement in the following manner: "Withdrawn upon the request of the Registrant, the Commission consenting thereto." If you have any questions or comments or require further information or documentation, please do not hesitate to call our General Counsel, Robert E. Pokusa at (301) 654-8300. Sincerely, /s/ Paul L. Perito Paul L. Perito, Esquire Chairman, President and Chief Operation Officer Star Scientific, Inc. cc: Walter E. Jospin, Esquire Paul, Hastings, Janofsky & Walker LLP Executive/Scientific/Regulatory Office -------------------------------------- 7475 Wisconsin Avenue Suite 850 Bethesda, MD 20814 Tel: 301-654-8300 . Fax: 301-654-9308

Dates Referenced Herein

This ‘RW’ Filing    Date    Other Filings
Filed on:9/24/01None on these Dates
9/21/01
 List all Filings 
Top
Filing Submission 0001021408-01-507214   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., Apr. 27, 8:18:37.1am ET